US regulator approves pill form of Wegovy weight-loss drug

BBC NewsTuesday, December 23, 2025 at 1:29:07 AM
US regulator approves pill form of Wegovy weight-loss drug
  • The US regulator has approved Wegovy in pill form, marking a significant shift in the weight-loss drug market by providing a non-injection option for patients. This approval represents a milestone for Novo Nordisk, as Wegovy becomes the first GLP-1 medication available in oral form for weight management.
  • This development is crucial for Novo Nordisk, as it expands the accessibility of Wegovy, potentially increasing its market share and addressing the growing demand for weight-loss solutions that are easier to administer.
  • However, the company faces challenges as recent trials of semaglutide, the active ingredient in Wegovy, have failed to show cognitive benefits for Alzheimer's patients, raising concerns about the drug's broader efficacy and impacting investor confidence amid fluctuating stock performance.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
US economy grows at fastest pace in two years
PositiveFinancial Markets
The US economy has shown significant growth, expanding at its fastest pace in two years, driven primarily by strong consumer spending. This unexpected surge indicates a robust economic recovery, suggesting that consumers are increasingly confident in their financial situations.
TikTok removes AI weight loss ads from fake Boots account
NegativeFinancial Markets
TikTok has removed advertisements for prescription-only weight loss drugs that were posted by a fake Boots account, featuring impersonated healthcare professionals. This action follows concerns about misleading advertising practices on social media platforms.

Ready to build your own newsroom?

Subscribe to unlock a personalised feed, podcasts, newsletters, and notifications tailored to the topics you actually care about